• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

参加马尔默饮食与运动预防试验的糖耐量受损男性,12年死亡率无增加。

No excess 12-year mortality in men with impaired glucose tolerance who participated in the Malmö Preventive Trial with diet and exercise.

作者信息

Eriksson K F, Lindgärde F

机构信息

Department of Medicine, University Hospital, Malmö, Sweden.

出版信息

Diabetologia. 1998 Sep;41(9):1010-6. doi: 10.1007/s001250051024.

DOI:10.1007/s001250051024
PMID:9754818
Abstract

Impaired glucose tolerance (IGT) is associated with increased mortality due to ischaemic heart disease (IHD), but as it is not known whether this excess mortality can be reduced by preventing or delaying the development of non-insulin-dependent diabetes mellitus (NIDDM), a long-term NIDDM prevention trial of dietary counselling and physical exercise was launched at Malmö, Sweden, the 12-year follow-up of which is reported here. At 12-year follow-up of 6956 men who underwent health screening at 48 years of age, an IGT intervention group (n = 288) who participated in a long-term NIDDM prevention programme were compared with an IGT non-randomised routine treatment group (n = 135), a diabetic group (n = 144), and the remainder, the normal glucose tolerance (NGT) group (n = 6389). The variables studied included the levels of blood glucose, plasma insulin, blood pressure, blood lipids, lung function and maximum oxygen uptake. Subjects with IGT were characterised by overweight, poor vital capacity, hypertension, hypertriglyceridaemia and hyperinsulinaemia. The mortality rate in the IGT intervention group was similar to that in the NGT group (6.5 vs 6.2 per 1000 person years at risk) and lower than that in the IGT routine treatment group (6.5 vs 14.0, p = 0.009). In the two IGT groups taken together, intervention but not body mass index, systolic blood pressure, smoking, cholesterol or the 2-h glucose level predicted mortality. Systolic blood pressure was a predictor of IHD mortality among IGT subjects; and in the cohort as a whole, body mass index, systolic blood pressure, hypercholesterolaemica, diabetes and smoking were predictors of IHD mortality. The findings suggest that a long-term intervention programme, with an emphasis on lifestyle changes, including dietary counselling and physical exercise, will reduce mortality in subjects with IGT who are at an increased risk of both developing NIDDM and of premature death due to IHD and other causes.

摘要

糖耐量受损(IGT)与缺血性心脏病(IHD)导致的死亡率增加相关,但由于尚不清楚通过预防或延缓非胰岛素依赖型糖尿病(NIDDM)的发生是否可以降低这种额外的死亡率,因此在瑞典马尔默开展了一项关于饮食咨询和体育锻炼的长期NIDDM预防试验,本文报告了该试验的12年随访结果。在对6956名48岁接受健康筛查的男性进行12年随访时,将参与长期NIDDM预防计划的IGT干预组(n = 288)与IGT非随机常规治疗组(n = 135)、糖尿病组(n = 144)以及其余的正常糖耐量(NGT)组(n = 6389)进行了比较。所研究的变量包括血糖、血浆胰岛素、血压、血脂、肺功能和最大摄氧量。IGT受试者的特征为超重、肺活量差、高血压、高甘油三酯血症和高胰岛素血症。IGT干预组的死亡率与NGT组相似(每1000人年风险中分别为6.5和6.2),且低于IGT常规治疗组(6.5对14.0,p = 0.009)。将两个IGT组合并来看,干预而非体重指数、收缩压、吸烟、胆固醇或2小时血糖水平可预测死亡率。收缩压是IGT受试者中IHD死亡率的一个预测因素;在整个队列中,体重指数、收缩压、高胆固醇血症、糖尿病和吸烟是IHD死亡率的预测因素。研究结果表明,一项强调生活方式改变(包括饮食咨询和体育锻炼)的长期干预计划将降低IGT受试者的死亡率,这些受试者患NIDDM以及因IHD和其他原因过早死亡的风险增加。

相似文献

1
No excess 12-year mortality in men with impaired glucose tolerance who participated in the Malmö Preventive Trial with diet and exercise.参加马尔默饮食与运动预防试验的糖耐量受损男性,12年死亡率无增加。
Diabetologia. 1998 Sep;41(9):1010-6. doi: 10.1007/s001250051024.
2
Lifestyle intervention in individuals with normal versus impaired glucose tolerance.对糖耐量正常与糖耐量受损个体的生活方式干预。
Eur J Clin Invest. 2007 Jul;37(7):535-43. doi: 10.1111/j.1365-2362.2007.01820.x.
3
Role of skeletal muscle-fibre type in regulation of glucose metabolism in middle-aged subjects with impaired glucose tolerance during a long-term exercise and dietary intervention.骨骼肌纤维类型在长期运动和饮食干预期间糖耐量受损中年受试者葡萄糖代谢调节中的作用
Diabetes Obes Metab. 2005 Nov;7(6):745-54. doi: 10.1111/j.1463-1326.2004.00466.x.
4
Review of previous impaired glucose tolerance intervention studies.既往糖耐量受损干预研究综述。
Diabet Med. 1996;13(3 Suppl 2):S20-2.
5
Glucose intolerance (diabetes and IGT) in a selected South Indian population with special reference to family history, obesity and lifestyle factors--the Chennai Urban Population Study (CUPS 14).特定南印度人群中的葡萄糖耐量异常(糖尿病和糖耐量受损):特别提及家族史、肥胖和生活方式因素——金奈城市人口研究(CUPS 14)
J Assoc Physicians India. 2003 Aug;51:771-7.
6
Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: a post-hoc analysis of the BIGPRO1 trial.在 BIGPRO1 试验的事后分析中,研究了二甲双胍治疗 1 年对上半身肥胖伴轻度葡萄糖异常的非糖尿病患者的代谢和心血管危险因素的影响。
Diabetes Metab. 2009 Nov;35(5):385-91. doi: 10.1016/j.diabet.2009.03.005. Epub 2009 Aug 7.
7
Randomised controlled trial evaluating lifestyle interventions in people with impaired glucose tolerance.评估糖耐量受损人群生活方式干预措施的随机对照试验。
Diabetes Res Clin Pract. 2006 May;72(2):117-27. doi: 10.1016/j.diabres.2005.09.018. Epub 2005 Nov 16.
8
Circulating lipids and cardiovascular risk in newly diagnosed non-insulin-dependent diabetic subjects in India.印度新诊断的非胰岛素依赖型糖尿病患者的循环脂质与心血管风险
Diabet Med. 1997 Sep;14(9):757-61. doi: 10.1002/(SICI)1096-9136(199709)14:9<757::AID-DIA472>3.0.CO;2-8.
9
Development and validation of a risk-score model for subjects with impaired glucose tolerance for the assessment of the risk of type 2 diabetes mellitus-The STOP-NIDDM risk-score.用于评估 2 型糖尿病风险的葡萄糖耐量受损患者风险评分模型的开发和验证——STOP-NIDDM 风险评分。
Diabetes Res Clin Pract. 2010 Feb;87(2):267-74. doi: 10.1016/j.diabres.2009.11.011. Epub 2009 Dec 22.
10
Factors determining normalization of glucose intolerance in middle-aged Swedish men and women: a 8-10-year follow-up.瑞典中年男性和女性糖耐量异常正常化的决定因素:一项8至10年的随访研究
Diabet Med. 2009 Apr;26(4):345-53. doi: 10.1111/j.1464-5491.2009.02685.x.

引用本文的文献

1
Effect of onset of type 2 diabetes on risks of cardiovascular disease and heart failure among new Zealanders with impaired glucose tolerance over 25 years: tapered-matched landmark analysis.25 年内新西兰糖耐量受损人群中 2 型糖尿病发病对心血管疾病和心力衰竭风险的影响:缩尾匹配标志分析。
Cardiovasc Diabetol. 2023 Jun 30;22(1):163. doi: 10.1186/s12933-023-01871-y.
2
Epidemiology of diabetes mellitus in Tunisia. HSHS 2 study (Hammam Sousse Sahloul Heart Study).突尼斯的糖尿病流行病学。HSHS 2 研究(哈马姆苏塞萨赫勒心脏研究)。
Tunis Med. 2022;100(3):229-240.
3
Potential Mechanisms for How Long-Term Physical Activity May Reduce Insulin Resistance.
长期体育活动可能降低胰岛素抵抗的潜在机制。
Metabolites. 2022 Feb 25;12(3):208. doi: 10.3390/metabo12030208.
4
Combined effects of maximal oxygen uptake and glucose status on mortality: The Prospective KIHD cohort study.最大摄氧量和葡萄糖状态对死亡率的综合影响:前瞻性 KIHD 队列研究。
Scand J Med Sci Sports. 2022 May;32(5):913-923. doi: 10.1111/sms.14135. Epub 2022 Feb 13.
5
The Role of Physical Activity in Nonalcoholic and Metabolic Dysfunction Associated Fatty Liver Disease.体育活动在非酒精性和代谢功能障碍相关脂肪性肝病中的作用
Biomedicines. 2021 Dec 7;9(12):1853. doi: 10.3390/biomedicines9121853.
6
Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study.二甲双胍和生活方式干预对糖尿病预防计划和糖尿病预防计划结果研究中死亡率的影响。
Diabetes Care. 2021 Dec;44(12):2775-2782. doi: 10.2337/dc21-1046. Epub 2021 Oct 25.
7
Glucocorticoid toxicity reduction with mepolizumab using the Glucocorticoid Toxicity Index.美泊利珠单抗通过糖皮质激素毒性指数降低糖皮质激素毒性。
Eur Respir J. 2022 Jan 20;59(1). doi: 10.1183/13993003.00160-2021. Print 2022 Jan.
8
The burden of type 2 diabetes pre-and during the COVID-19 pandemic - a review.2型糖尿病在新冠疫情之前及期间的负担——一项综述
J Diabetes Metab Disord. 2020 Oct 19;19(2):1357-1365. doi: 10.1007/s40200-020-00656-4. eCollection 2020 Dec.
9
Regression from prediabetes to normal glucose regulation: State of the science.从糖尿病前期回归到正常血糖调节:科学现状。
Exp Biol Med (Maywood). 2020 May;245(10):889-896. doi: 10.1177/1535370220915644. Epub 2020 Mar 25.
10
Implications of using HBA1 as a diagnostic marker for diabetes.使用糖化血红蛋白A1(HBA1)作为糖尿病诊断标志物的意义。
Diabetol Int. 2015 Nov 6;7(1):18-24. doi: 10.1007/s13340-015-0244-9. eCollection 2016 Mar.